Skip to content

Alto Ingredients, Inc. ALTO Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value at other companies

Repligen logo
RepligenRGEN
$155.80
AMN Healthcare logo
AMN HealthcareAMN
$80.79-9.9%
Kopin logo
KopinKOPN
$1.62
Heartland Express logo
Heartland ExpressHTLD
$10.71-5.1%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$54.10+21.0%
Heartland Express logo
Heartland ExpressHTLD
$10.48-4.3%

Other financials

Income statement

See full
Revenue$224.7M-0.8%
Gross profit$9.2M+610%
Operating income$2.5M+128%
Net income$4.3M+137%
EPS (diluted)$0.05+131%

Balance sheet

See full
Cash & equivalents$21.6M-20.3%
Total debt$91.3M-30.5%
Total equity$249.9M+16.8%
Total assets$386.3M-4.0%

Cash flow

See full
Operating cash flow$4.2M+123%
CapEx$909.0K+70.9%
Free cash flow$3.3M+118%

Valuation

See full
Market cap$385.88M+342%
Enterprise value$455.51M+138%
P/E13.2×
P/S0.4×+0.3×

Profitability

See full
Gross margin5%
Operating margin2.1%+1.2pp
Net margin3.2%+1.9pp
FCF margin3.4%

Returns & leverage

See full
Return on equity12.6%+7.6pp
Debt / equity0.4×-0.2×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Alto Ingredients, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.

The official record: Alto Ingredients, Inc.’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Ingredients, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alto Ingredients, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value?
Alto Ingredients, Inc. (ALTO) reported share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value of $1.53 in Q4 2025.
What is the long-term trend for Alto Ingredients, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value?
Over 4 years (2020 to 2025), Alto Ingredients, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value has grown at a 3.4% compound annual growth rate (CAGR), from $1.34 to $1.53.